Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas

Hiroshi Miyata, Makoto Yamasaki, Yukinori Kurokawa, Shuji Takiguchi, Kiyokazu Nakajima, Yoshiyuki Fujiwara, Koji Konishi, Masaki Mori, Yuichiro Doki

Research output: Contribution to journalArticle

42 Citations (Scopus)

Abstract

Background: Approximately half of patients who undergo curative resection for esophageal cancers develop recurrence postoperatively. The factors affecting survival after such recurrence remain largely unknown. Methods: To investigate factors affecting survival after recurrence in patients who had undergone curative resection for esophageal cancer, we retrospectively reviewed data for 461 patients who underwent curative esophagectomy with or without preoperative therapy for esophageal squamous cell carcinoma from January 1996 to December 2007. The correlations between several clinicopathological factors and survival after recurrence were examined. Results: Recurrence occurred in 196 of 461 patients (42.5%), with a median survival time after recurrence of 8.2 months. Multivariate analysis identified advanced tumor stage, preoperative chemoradiotherapy (CRT), number of recurrent tumors, and the presence of recurrence at the local site and liver as associated with shortened survival after recurrence. The analysis also indicated that treatment of the recurrence prolonged survival regardless of the treatment type. Although the pattern of recurrence did not significantly differ according to type of preoperative therapy, patients who underwent preoperative CRT were less often treated with radiotherapy for recurrence. Patients with multiple recurrent tumors less often received radiotherapy or surgery than those with a solitary recurrence. Chemotherapy for recurrence was not associated with either preoperative therapy or the number of recurrences. Conclusions: Our retrospective study showed that multiple recurrent tumors and preoperative CRT limit the available treatment for recurrence and thereby are associated with poor prognosis. Vigorous treatment for recurrence can extend survival after recurrence in patients who undergo esophagectomy.

Original languageEnglish
Pages (from-to)3353-3361
Number of pages9
JournalAnnals of Surgical Oncology
Volume18
Issue number12
DOIs
Publication statusPublished - Nov 1 2011
Externally publishedYes

Fingerprint

Recurrence
Survival
Chemoradiotherapy
Esophageal Squamous Cell Carcinoma
Esophagectomy
Esophageal Neoplasms
Therapeutics
Neoplasms
Radiotherapy
Multivariate Analysis
Retrospective Studies
Drug Therapy
Liver

All Science Journal Classification (ASJC) codes

  • Surgery
  • Oncology

Cite this

Miyata, H., Yamasaki, M., Kurokawa, Y., Takiguchi, S., Nakajima, K., Fujiwara, Y., ... Doki, Y. (2011). Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas. Annals of Surgical Oncology, 18(12), 3353-3361. https://doi.org/10.1245/s10434-011-1747-7

Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas. / Miyata, Hiroshi; Yamasaki, Makoto; Kurokawa, Yukinori; Takiguchi, Shuji; Nakajima, Kiyokazu; Fujiwara, Yoshiyuki; Konishi, Koji; Mori, Masaki; Doki, Yuichiro.

In: Annals of Surgical Oncology, Vol. 18, No. 12, 01.11.2011, p. 3353-3361.

Research output: Contribution to journalArticle

Miyata, H, Yamasaki, M, Kurokawa, Y, Takiguchi, S, Nakajima, K, Fujiwara, Y, Konishi, K, Mori, M & Doki, Y 2011, 'Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas', Annals of Surgical Oncology, vol. 18, no. 12, pp. 3353-3361. https://doi.org/10.1245/s10434-011-1747-7
Miyata, Hiroshi ; Yamasaki, Makoto ; Kurokawa, Yukinori ; Takiguchi, Shuji ; Nakajima, Kiyokazu ; Fujiwara, Yoshiyuki ; Konishi, Koji ; Mori, Masaki ; Doki, Yuichiro. / Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas. In: Annals of Surgical Oncology. 2011 ; Vol. 18, No. 12. pp. 3353-3361.
@article{d9cb07bcb12e40db8c71b3fe7a1d3e08,
title = "Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas",
abstract = "Background: Approximately half of patients who undergo curative resection for esophageal cancers develop recurrence postoperatively. The factors affecting survival after such recurrence remain largely unknown. Methods: To investigate factors affecting survival after recurrence in patients who had undergone curative resection for esophageal cancer, we retrospectively reviewed data for 461 patients who underwent curative esophagectomy with or without preoperative therapy for esophageal squamous cell carcinoma from January 1996 to December 2007. The correlations between several clinicopathological factors and survival after recurrence were examined. Results: Recurrence occurred in 196 of 461 patients (42.5{\%}), with a median survival time after recurrence of 8.2 months. Multivariate analysis identified advanced tumor stage, preoperative chemoradiotherapy (CRT), number of recurrent tumors, and the presence of recurrence at the local site and liver as associated with shortened survival after recurrence. The analysis also indicated that treatment of the recurrence prolonged survival regardless of the treatment type. Although the pattern of recurrence did not significantly differ according to type of preoperative therapy, patients who underwent preoperative CRT were less often treated with radiotherapy for recurrence. Patients with multiple recurrent tumors less often received radiotherapy or surgery than those with a solitary recurrence. Chemotherapy for recurrence was not associated with either preoperative therapy or the number of recurrences. Conclusions: Our retrospective study showed that multiple recurrent tumors and preoperative CRT limit the available treatment for recurrence and thereby are associated with poor prognosis. Vigorous treatment for recurrence can extend survival after recurrence in patients who undergo esophagectomy.",
author = "Hiroshi Miyata and Makoto Yamasaki and Yukinori Kurokawa and Shuji Takiguchi and Kiyokazu Nakajima and Yoshiyuki Fujiwara and Koji Konishi and Masaki Mori and Yuichiro Doki",
year = "2011",
month = "11",
day = "1",
doi = "10.1245/s10434-011-1747-7",
language = "English",
volume = "18",
pages = "3353--3361",
journal = "Annals of Surgical Oncology",
issn = "1068-9265",
publisher = "Springer New York",
number = "12",

}

TY - JOUR

T1 - Survival factors in patients with recurrence after curative resection of esophageal squamous cell carcinomas

AU - Miyata, Hiroshi

AU - Yamasaki, Makoto

AU - Kurokawa, Yukinori

AU - Takiguchi, Shuji

AU - Nakajima, Kiyokazu

AU - Fujiwara, Yoshiyuki

AU - Konishi, Koji

AU - Mori, Masaki

AU - Doki, Yuichiro

PY - 2011/11/1

Y1 - 2011/11/1

N2 - Background: Approximately half of patients who undergo curative resection for esophageal cancers develop recurrence postoperatively. The factors affecting survival after such recurrence remain largely unknown. Methods: To investigate factors affecting survival after recurrence in patients who had undergone curative resection for esophageal cancer, we retrospectively reviewed data for 461 patients who underwent curative esophagectomy with or without preoperative therapy for esophageal squamous cell carcinoma from January 1996 to December 2007. The correlations between several clinicopathological factors and survival after recurrence were examined. Results: Recurrence occurred in 196 of 461 patients (42.5%), with a median survival time after recurrence of 8.2 months. Multivariate analysis identified advanced tumor stage, preoperative chemoradiotherapy (CRT), number of recurrent tumors, and the presence of recurrence at the local site and liver as associated with shortened survival after recurrence. The analysis also indicated that treatment of the recurrence prolonged survival regardless of the treatment type. Although the pattern of recurrence did not significantly differ according to type of preoperative therapy, patients who underwent preoperative CRT were less often treated with radiotherapy for recurrence. Patients with multiple recurrent tumors less often received radiotherapy or surgery than those with a solitary recurrence. Chemotherapy for recurrence was not associated with either preoperative therapy or the number of recurrences. Conclusions: Our retrospective study showed that multiple recurrent tumors and preoperative CRT limit the available treatment for recurrence and thereby are associated with poor prognosis. Vigorous treatment for recurrence can extend survival after recurrence in patients who undergo esophagectomy.

AB - Background: Approximately half of patients who undergo curative resection for esophageal cancers develop recurrence postoperatively. The factors affecting survival after such recurrence remain largely unknown. Methods: To investigate factors affecting survival after recurrence in patients who had undergone curative resection for esophageal cancer, we retrospectively reviewed data for 461 patients who underwent curative esophagectomy with or without preoperative therapy for esophageal squamous cell carcinoma from January 1996 to December 2007. The correlations between several clinicopathological factors and survival after recurrence were examined. Results: Recurrence occurred in 196 of 461 patients (42.5%), with a median survival time after recurrence of 8.2 months. Multivariate analysis identified advanced tumor stage, preoperative chemoradiotherapy (CRT), number of recurrent tumors, and the presence of recurrence at the local site and liver as associated with shortened survival after recurrence. The analysis also indicated that treatment of the recurrence prolonged survival regardless of the treatment type. Although the pattern of recurrence did not significantly differ according to type of preoperative therapy, patients who underwent preoperative CRT were less often treated with radiotherapy for recurrence. Patients with multiple recurrent tumors less often received radiotherapy or surgery than those with a solitary recurrence. Chemotherapy for recurrence was not associated with either preoperative therapy or the number of recurrences. Conclusions: Our retrospective study showed that multiple recurrent tumors and preoperative CRT limit the available treatment for recurrence and thereby are associated with poor prognosis. Vigorous treatment for recurrence can extend survival after recurrence in patients who undergo esophagectomy.

UR - http://www.scopus.com/inward/record.url?scp=83055188446&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=83055188446&partnerID=8YFLogxK

U2 - 10.1245/s10434-011-1747-7

DO - 10.1245/s10434-011-1747-7

M3 - Article

C2 - 21537861

AN - SCOPUS:83055188446

VL - 18

SP - 3353

EP - 3361

JO - Annals of Surgical Oncology

JF - Annals of Surgical Oncology

SN - 1068-9265

IS - 12

ER -